Connect Sign InEmerging Viral Diseases: A 2025 Update for Laboratorians
Following the COVID-19 pandemic, clinical laboratories continue to face new, challenging outbreaks. In this lecture we will explore some recently emerging (influenza A(H5) and mpox) and reemerging (measles and pertussis) pathogens that may be encountered in the clinical laboratory. Special emphasis will be placed on how these outbreaks originated and how lab testing contributes in helping control the spread. A practical discussion will focus on challenges in assay validation for newly emerging or reemerging pathogens and what steps your laboratory can take to be prepared for the next outbreak.
Dr. Benjamin Bradley is a medical director of high consequence pathogen response, virology, and molecular infectious disease at ARUP Laboratories, and an assistant professor (clinical) at the University of Utah School of Medicine. He received a medical degree and a doctorate degree from Tulane University School of Medicine. He completed his residency in anatomic and clinical pathology at the University of Washington Medical Center as well as a fellowship in clinical microbiology at the University of Utah and ARUP Laboratories. Dr. Bradley is certified by the American Board of Pathology in anatomic and clinical pathology. He received the Jacob Ambrose Storck prize in 2017, the Strandjord-Clayton award and the Paul Strandjord Young Investigator award in 2020. His research interests include development and clinical implementation of viral diagnostics, direct-from-tissue detection of infectious organisms, and infectious disease pathology education.
